Dietary Tracking App for Amyloidosis
(DRITA Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to learn about malnutrition and weight loss in patients with Amyloidosis. The main question it aims to answer is: Is it feasible to use a low-cost nutrition-based application (apps) for use on a smartphone to obtain detailed information on caloric intake in Amyloidosis patients Participants will be asked to: * Download the MyFitnessPal application on their smartphone and view an online tutorial * After a week of practice, from weeks 2-9, participants will enter daily dietary intake as well as daily herbal/alternative supplement intake into the MyFitnessPal application on their smartphone. * complete a questionnaire prior to starting the application, after week 2 and at week 10 after starting the application
Do I need to stop my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications. It focuses on tracking dietary and supplement intake using a smartphone app.
What data supports the effectiveness of the treatment using the MyFitnessPal app for dietary tracking in amyloidosis patients?
Research shows that using apps for dietary tracking can be effective in improving nutrition habits. For example, studies on similar apps have shown positive effects in reducing fat intake and increasing fruit and vegetable consumption. Additionally, healthcare professionals find these apps acceptable and useful for patient care.12345
Is the Dietary Tracking App for Amyloidosis safe for humans?
How does the dietary tracking app treatment for amyloidosis differ from other treatments?
The dietary tracking app for amyloidosis is unique because it uses mobile technology to help patients monitor their diet, which can improve adherence to dietary recommendations and potentially impact disease management. Unlike traditional treatments that may focus on medication or other interventions, this app emphasizes self-monitoring and real-time feedback to support dietary changes.47101112
Research Team
Jeffrey A. Zonder
Principal Investigator
Barbara Ann Karmanos Cancer Institute
Eligibility Criteria
This trial is for English-speaking adults over 18 with any type of amyloidosis who are willing to use the MyFitnessPal app on their smartphone. It's not suitable for those with cognitive or perceptual disturbances, or anyone planning a stem cell or organ transplant within 12 weeks after joining.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Practice Phase
Participants download the MyFitnessPal application and view an online tutorial
Data Collection
Participants enter daily dietary intake and supplement intake into the MyFitnessPal application
Follow-up
Participants complete a questionnaire and adherence is assessed
Treatment Details
Interventions
- Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app) (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Barbara Ann Karmanos Cancer Institute
Lead Sponsor